Astria Therapeutics, Inc.

ATXSNASDAQHealthcare

$12.58

+$0.00(+0.00%)

Market Cap$718127262

P/E Ratio—

52W High$13.29

52W Low$3.555

Avg Volume1.1M

Open$12.58

Beta0.02

Overview

Astria Therapeutics, Inc. (ATXS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ATXS · as of Mar 11, 2025

Latest filing snapshot

+19+32.20%vs prior year

Astria Therapeutics, Inc. (ATXS) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2024-12-31·Full-time · Global

Total Employees

Change (1Y)

+19

Growth % (1Y)

+32.20%

Revenue / Employee

—

Net Income / Employee

$-1.21M

Market Cap

$718M

ATXS Employee Count

2015 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2025-03-11	2024-12-31	78	+19	+32.20%
2024-03-04	2023-12-31	59	+17	+40.48%
2023-03-22	2022-12-31	42	+13	+44.83%
2022-03-10	2021-12-31	29	+9	+45.00%
2021-03-11	2020-12-31	20	-7	-25.93%
2020-03-10	2019-12-31	27	+3	+12.50%
2019-03-14	2018-12-31	24	-12	-33.33%
2018-03-15	2017-12-31	36	-2	-5.26%
2017-03-16	2016-12-31	38	+1	+2.70%
2016-03-15	2015-12-31	37	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

IOVA

Iovance Biotherapeutics, Inc.

838$1.5B #2

DNA

Ginkgo Bioworks Holdings, Inc.

Day One Biopharmaceuticals, Inc.

Astria Therapeutics, Inc.YOU

78$718M #7

AVBP

ArriVent BioPharma, Inc. Common Stock

52$1.4B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ATXS peer comparison

About ATXS employees

ATXS Employees · Headcount

Astria Therapeutics, Inc. (ATXS) employee data is sourced from the annual SEC 10-K filing. As of 2024, Astria Therapeutics, Inc. had 78 full-time employees globally. Full-time employees only. Global consolidated headcount.

Astria Therapeutics, Inc.'s workforce increased by 19 (32.20%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ATXS Employees · 5 questions

As of the latest SEC 10-K filing (2024), Astria Therapeutics, Inc. had 78 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Astria Therapeutics, Inc. employee counthow many employees does Astria Therapeutics, Inc. haveATXS total employees 2024

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-03-11